ALXO Alx Oncology Holdings Inc

Price (delayed)

$1.675

Market cap

$225.39M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.49

Enterprise value

$201.62M

?
Relative Growth: Rel. Growth: 21
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 10

ALX Oncology Holdings Inc. operates as a clinical stage immuno-oncology company. The Company focuses on helping patients fight cancer by developing therapies that bridge the innate and adaptive immune system. ...

Highlights
Alx Oncology Holdings's equity has surged by 71% YoY
The EPS is up by 39% year-on-year and by 22% since the previous quarter

Key stats

What are the main financial stats of ALXO

ALXO stock price

How has the Alx Oncology Holdings stock price performed over time
Intraday
0.3%
1 week
-11.38%
1 month
-10.9%
1 year
213.61%
YTD
48.23%
QTD
-16.46%

Financial performance

How have Alx Oncology Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$91.17M
Net income
-$88.87M
Gross margin
N/A
Net margin
N/A
ALXO's operating income is up by 33% YoY and by 12% QoQ
ALXO's net income is up by 32% year-on-year and by 13% since the previous quarter

Price vs fundamentals

How does ALXO's price correlate with its fundamentals

Growth

What is Alx Oncology Holdings's growth rate over time

Valuation

What is Alx Oncology Holdings stock price valuation
P/E
N/A
P/B
1.46
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 39% year-on-year and by 22% since the previous quarter
Alx Oncology Holdings's equity has surged by 71% YoY
The price to book (P/B) is 31% less than the 5-year quarterly average of 2.1 and 15% less than the last 4 quarters average of 1.7

Efficiency

How efficient is Alx Oncology Holdings business performance
ALXO's return on invested capital is down by 33% year-on-year but it is up by 27% since the previous quarter
ALXO's return on equity is up by 32% since the previous quarter but it is down by 19% year-on-year
The return on assets is up by 25% since the previous quarter but it has declined by 10% year-on-year

Dividends

What is ALXO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALXO.

Financial health

How did Alx Oncology Holdings financials performed over time
The total assets is up by 48% year-on-year
The quick ratio has increased by 33% year-on-year
The debt is 94% smaller than the equity
Alx Oncology Holdings's debt to equity has plunged by 84% from the previous quarter and by 45% YoY
Alx Oncology Holdings's equity has surged by 71% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.